Synlett
DOI: 10.1055/a-2595-8088
letter
Small Molecules in Medicinal Chemistry

Exploring Tetrahydroquinoline Derivatives: A New Frontier in Cancer Treatment

Suman K. Shaw‡
a   Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Rajdeep Dey‡
a   Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Ruchi Yadav
a   Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Aliasgar Baldiwala
b   Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Manan Patel
b   Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Bhumika D. Patel
a   Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Hardik G. Bhatt
a   Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Gopal Natesan
a   Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
,
Abhishek Jha
c   Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
,
Udit Chaube  ∗
a   Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad 382481, India
› Institutsangaben
This work was supported by the Minor Research Project IPNU/2024-26/144 funded by Nirma University, Ahmedabad, India.
› Weitere Informationen
   Lizenzen und Reprints Alle Artikel dieser Rubrik


Abstract

Tetrahydroquinoline derivatives are emerging as promising anticancer agents due to their versatile biological activities. In this study, we designed, synthesized, and evaluated six novel tetrahydroquinoline derivatives with anticancer potential. The compounds were synthesized by nitration, benzoylation, and reduction, achieving high yields and structural diversity. Molecular-docking studies on the mTOR protein (PDB ID: 4JT6) revealed strong binding affinities, with key interactions at active-site residues. Molecular dynamics simulations in GROMACS (50 ns) confirmed the stability of the compound–protein complexes. In vitro cytotoxicity assays against A549, MDA-MB-231, and MCF-7 cancer cell lines showed potent activities, with one product displaying an IC50 o

Key words

anticancer drugs - tetrahydroquinolines - molecular docking

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/a-2595-8088.
  • Supporting Information


Publikationsverlauf

Eingereicht: 27. Februar 2025

Angenommen nach Revision: 28. April 2025

Accepted Manuscript online:
28. April 2025

Artikel online veröffentlicht:
12. Juni 2025

© 2025. Thieme. All rights reserved

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References and Notes

  • 1 Noronha V, Budukh A, Chaturvedi P, Anne S, Punjabi A, Bhaskar M, Sahoo TP, Menon N, Shah M, Batra U, Nathany S, Kumar R, Shetty O, Ghodke TP, Mahajan A, Chakrabarty N, Hait S, Tripathi SC, Chougule A, Chandrani P, Tripathi VK, Jiwnani S, Tibdewal A, Maheshwari G, Kothari R, Patil VM, Bhat RS, Khanderia M, Mahajan V, Prakash R, Sharma S, Jabbar AA, Yadav BK, Uddin AF. M. K, Dutt A, Prabhash K. Lancet Reg. Health Southeast Asia 2024; 27: 100430
    Suche in Google Scholar
  • 2 Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Ca-Cancer J. Clin. 2024; 74: 229
    Suche in Google Scholar
  • 3 Dey R, Vishwakarma K, Patel B, Vyas VK, Bhatt H. ChemistrySelect 2024; 9: e202404444
    Suche in Google Scholar
  • 4 Guo Q, Liu L, Chen Z, Fan Y, Zhou Y, Yuan Z, Zhang W. Front. Oncol. 2022; 12: 945102
    Suche in Google Scholar
  • 5 Vishwakarma K, Dey R, Bhatt H. Eur. J. Med. Chem. 2023; 249: 115121
    Suche in Google Scholar
  • 6 Shaik R, Malik MS, Basavaraju S, Qurban J, Al-Subhi FM. M, Badampudi S, Peddapaka J, Shaik A, Abd-El-Aziz A, Moussa Z, Ahmed SA. Daru J. Pharm. Sci. 2024; 33: 4
    Suche in Google Scholar
  • 7 Alkhathami AG, Pallathadka H, Shah S, Ganesan S, Sharma A, Devi S, Mustafa YF, Alasheqi MQ, Kadhim AJ, Zwamel AH. Med. Oncol. 2024; 42: 28
    Suche in Google Scholar
  • 8 Win T, Kharofa J, Frankart AJ. Support Care Cancer 2025; 33: 11
    Suche in Google Scholar
  • 9 Peng Y, Li D, Wampfler J, Luo Y.-H, Kumar A, Gu Z, Kosuru N, Yu NY, Wang Z, Leventakos K, Ernani V, Yang P. Oncol. Rep. 2024; 53: 25
    Suche in Google Scholar
  • 10 Thaker A, Patel S, Dey R, Shaw S, Patel B, Bhatt H, Chaube UJ. Synlett 2024; in press
  • 11 Faheem Faheem, Karan Kumar B, Chandra Sekhar KV. G, Chander S, Kunjiappan S, Murugesan S. RSC Adv. 2021; 11: 12254
    Suche in Google Scholar
  • 12 Sridharan V, Suryavanshi PA, Menéndez JC. Chem. Rev. 2011; 111: 7157
    Suche in Google Scholar
  • 13 Zhao Y.-Q, Li X, Guo H.-Y, Shen Q.-K, Quan Z.-S, Luan T. Molecules 2023; 28: 6478
    Suche in Google Scholar
  • 14 Błaszczyk A, Skolimowski J. Chem.-Biol. Interact. 2006; 162: 70
    Suche in Google Scholar
  • 15 Wu J, Tan X, Wu W, Jiang H. Nat. Commun. 2024; 15: 6776
    Suche in Google Scholar
  • 16 Domingo LR, Aurell MJ, Sáez JA, Mekelleche SM. RSC Adv. 2014; 4: 25268
    Suche in Google Scholar
  • 17 Vielhaber T, Heizinger C, Topf C. J. Catal. 2021; 404: 451
    Suche in Google Scholar
  • 18 Magyar A, Wölfling J, Kubas M, Cuesta Seijo JA, Sevvana M, Herbst-Irmer R, Forgó P, Schneider G. Steroids 2004; 69: 301
    Suche in Google Scholar
  • 19 Chaube U, Dey R, Shaw S, Patel BD, Bhatt HG. Future Med. Chem. 2022; 14: 1789
    Suche in Google Scholar
  • 20 Ryczkowska M, Maciejewska N, Olszewski M, Witkowska M, Makowiec S. Sci. Rep. 2022; 12: 9985
    Suche in Google Scholar
  • 21 Fathy U, Azzam MA, Mahdy F, El-Maghraby S, Allam RM. J. Heterocycl. Chem. 2020; 57: 2108
    Suche in Google Scholar
  • 22 Faheem, Karan Kumar B, Chandra Sekhar KV. G, Chander S, Kunjiappan S, Murugesan S. Expert Opin. Drug Discovery 2021; 16: 1119
    Suche in Google Scholar
  • 23 Chaube U, Bhatt H. Mol. Diversity 2017; 21: 741
    Suche in Google Scholar
  • 24 Chaube UJ, Rawal R, Jha AB, Variya B, Bhatt HG. Bioorg. Chem. 2021; 106: 104501
    Suche in Google Scholar
  • 25 He G, Chen C, Wang T, Wu F, Ouyang L, Xiang M, Jiang Q, Huang W, Peng C. Drug Des. Devel. Theor. 2014; 8: 1195
    Suche in Google Scholar
  • 26 Dey R, Shaw S, Bhatt H, Patel B, Yadav R, Chaube U. J. Mol. Struct. 2024; 1318: 139330
    Suche in Google Scholar
  • 27 Yang L, Chiu K. Tetrahedron Lett. 1997; 38: 7307
    Suche in Google Scholar
  • 28 Njoroge FG, Vibulbhan B, Pinto P, Chan T.-M, Osterman R, Remiszewski S, Del Rosario J, Doll R, Girijavallabhan V, Ganguly AK. J. Org. Chem. 1998; 63: 445
    Suche in Google Scholar
  • 29 Ashenhurst J.; Electrophilic Aromatic Substitutions (2): Nitration and Sulfonation; Master Organic Chemistry LLC: Nashville, 2025; accessed May 19, 2025: https://www.masterorganicchemistry.com/2018/04/30/electrophilic-aromatic-substitutions-2-nitration-and-sulfonation
  • 30 Román T, Acosta G, Cárdenas C, de la Torre BG, Guzmán F, Albericio F. Methods Protoc. 2023; 6: 110
    Suche in Google Scholar
  • 31 Egelund PH. G, Jadhav S, Martin V, Johansson Castro H, Richner F, Le Quement ST, Dettner F, Lechner C, Schoenleber R, Sejer Pedersen D. ACS Sustainable Chem. Eng. 2021; 9: 14202
    Suche in Google Scholar
  • 32 Jarret RM, Keil N, Allen S, Cannon L, Coughlan J, Cusumano L, Nolan B. J. Chem. Educ. 1989; 66: 1056
    Suche in Google Scholar
  • 33 Denton EH, Stepanović O, Morandi B. Chem. Eur. J. 2024; 30: e202401852
    Suche in Google Scholar
  • 34 Yu M, Ouyang D, Wang L, Liu Y.-N. Molecules 2024; 29: 4353
    Suche in Google Scholar
  • 35 Dasgupta HR, Mukherjee S, Ghosh P. Tetrahedron Lett. 2019; 60: 151028
    Suche in Google Scholar
  • 36 Welch J. In Encyclopedia of Physical Science and Technology, 3rd ed. Meyers RA. Academic Press; San Diego: 2001: 497
    Suche in Google Scholar
  • 37 Verma P, Xiang LZ, Chaube U, Natesan G. ChemistrySelect 2024; 9: e202403009
    Suche in Google Scholar
  • 38 Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E. SoftwareX 2015; 1–2: 19
    Suche in Google Scholar
  • 39 Páll S, Abraham MJ, Kutzner C, Hess B, Lindahl E. In International Conference on Exascale Applications and Software, EASC 2014, Stockholm, Sweden, April 2–3, 2014, Revised Selected Papers. Markidis S, Laure E. Springer eBooks; Cham: 2015: 3
    Suche in Google Scholar
  • 40 3,5-Difluoro-N-[1-(tetrahydro-2H-pyran-4-ylcarbonyl)-1,2,3,4-tetrahydroquinolin-7-yl]benzamide (13a); Typical Procedure Me3NH (4.9 mmol, 0.46 mL) was added dropwise to a solution of compound 11a (1.7 mmol, 0.5 g) in CH2Cl2, and the mixture was stirred for 30 min at r.t. 3,5-Difluorobenzoyl chloride (1.6 mmol, 0.28 g) was added, and the resulting mixture was stirred for 1 h, then poured onto crushed ice. The mixture was extracted with CH2Cl2, and the extracts were dried (Na2SO4), concentrated, and purified by column chromatography to give a light-yellow solid; yield: 39.46%; mp 206–208 °C; HPLC purity: 99.45%. 1H NMR (400 MHz, CDCl3): δ = 1.68–1.65 (d, J = 12 Hz, 4 H, CH2), 1.99–1.92 (m, 4 H, CH2), 2.75–2.71 (t, J = 12 Hz, 2 H, CH2), 3.28 (s, 1 H, CH), 3.44–3.27 (t, J = 12 Hz, 2 H, CH2), 4.0–3.97 (d, J = 12 Hz, 2 H, CH2), 7.045–7.00 (t, J = 8 Hz, 2 H, ArCH); 7.18–7.13 (d, J = 8 Hz, 1 H, ArCH), 7.48–7.41 (m, 1 H, ArCH), 7.83 (s, 1 H, ArCH), 7.86 (s, 1 H, NH–CO). 13C NMR (100 MHz, CDCl3): δ = 24.16, 26.32, 29.43, 29.66, 31.40, 38.60, 42.98, 67.05, 112.0, 112.25, 114.21, 114.41, 114.61, 116.20, 128.87, 132.00, 132.11, 135.43, 139.33, 158.65, 161.1, 174.86. MS (EI): m/z [M + H]+ calcd for C22H23F2N2O3: 400.43; found: 401.49.